Our current model is able to explain survival trends in breast cancer, but not in colorectal cancer, thus highlighting different possible coupling of ELF3 with EMT and/or other axes of plasticity, and the interplay of these axes of plasticity in determining patient outcome. Here, ELF3 is linked to breast cancer.